• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr David Kingdon on the Factors Predicting CBT Success in Psychosis

Video

David Kingdon, MD, professor of mental health care delivery, University of Southampton, discussed the settings and circumstances that make it more likely that cognitive behavioral therapy (CBT) will have a positive impact on patients with psychosis.

David Kingdon, MD, professor of mental health care delivery, University of Southampton, discussed the settings and circumstances that make it more likely that cognitive behavioral therapy (CBT) will have a positive impact on patients with psychosis.

Transcript

What are the factors that predict success in using CBT with a particular patient with psychosis?

I think when people are starting to use these techniques, it does seem that that little chink of insight is helpful if they’re not absolutely convinced, or distressing voices, they seem to work with. But in my experience and in others’ experience, I’ve worked in a psychiatric intensive care unit and on an acute admission ward, and in those circumstances people want to talk about their symptoms—they want to talk about it, they want to get out of hospital. In fact, they will engage then in a process of trying to explain what they believe, and that’s a time when you can really work very, very effectively with them.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.